|
Photoselective vaporization for the treatment of benign prostatic hyperplasia |
Bowen JM, Whelan JP, Hopkins RB, Burke N, Woods EA, McIsaac GP, O'Reilly DJ, Xie F, Sehatzadeh S, Levin L, Mathew SP, Patterson LL, Goeree R, Tarride J-E |
|
|
Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Bowen JM, Whelan JP, Hopkins RB, Burke N, Woods EA, McIsaac GP, O'Reilly DJ, Xie F, Sehatzadeh S, Levin L, Mathew SP, Patterson LL, Goeree R, Tarride J-E. Photoselective vaporization for the treatment of benign prostatic hyperplasia. Toronto: Health Quality Ontario (HQO). Ontario Health Technology Assessment Series (OHTAS) 13(2). 2013 Authors' conclusions For men with lower urinary tract symptoms due to an enlarged prostate, a laser treatment called
photoselective vaporization of the prostate (or PVP) is just as effective as surgery. PVP does not require
an overnight stay in the hospital for most men, and it costs almost $1,000 less. This report describes the
results of a study that collected information about treatment outcomes, quality of life, and health care use
related to PVP and surgery in Ontario. Indexing Status Subject indexing assigned by CRD MeSH Laser Therapy; Prostatic Hyperplasias Language Published English Country of organisation Canada English summary An English language summary is available. Address for correspondence Evidence Development and Standards, Health Quality Ontario, 130 Bloor Street West, 10th floor, Toronto, Ontario Canada M5S 1N5 Email: EDSinfo@hqontario.ca AccessionNumber 32014000046 Date abstract record published 10/01/2014 |
|
|
|